while the proportion of patients with chronic liver failure from NASH increased by almost threefold (P< .05). Moreover, the same data showed the proportion of patients with hepatocellular carcinoma from HCV or ALD decreased significantly (P< .05),...
There are always risks; however, these agents have a significantly superior safety profile compared with prior therapy. Sustained virologic response (or “cure”) decreases the risk of progressive liver disease, cirrhosis, decompensation, transplantation,...
通信作者:陆伦根,Email:lungenlu1965@163.com 丙型肝炎病毒根除后肝纤维化逆转基础和临床研究 【摘要】 丙型肝炎病毒(HCV)感染是导致肝纤维化、肝硬化和肝细胞癌的主要原因。HCV持续损伤肝脏,肝脏纤维组织产生超过了肝脏的降解能力,细胞...